Brief: Nu-Med Plus Closely Monitoring Outcomes On Two New Human Clinical Trials Using Inhaled Nitric Oxide In Treatment Of Covid-19

Nu-Med Plus

25/03/2020 10:04

March 25 (Reuters) - Nu-Med Plus Inc  NUMD.PK :
    * NU-MED PLUS CLOSELY MONITORING OUTCOMES ON TWO NEW HUMAN
CLINICAL TRIALS USING INHALED NITRIC OXIDE IN TREATMENT OF
COVID-19

Source text for Eikon:  ID:nGNX4jpmv9 
Further company coverage:  NUMD.PK 

 ((Reuters.Briefs@thomsonreuters.com;))